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Introduction
Mammography and sonography are the standard imaging
techniques for detection and evaluation of breast disease
[1]. Mammography is the most established screening
modality [2]. Especially in young women and women with
dense breasts, sonography appears superior to mammog-
raphy, and differentiation between solid tumours and cysts
is easier. Sensitivity and specificity of sonography or mam-
mography are higher if sonography and mammography are
combined [3].
It is generally accepted that MR mammography is the
most sensitive technique for diagnosis of breast cancer,
whereas the reported specificity of MR mammography
varies [4–12]. In those studies, MR mammography was
performed and evaluated by highly specialized radiolo-
gists in a research setting. It was therefore the purpose
of the present prospective study to compare the validity
of MR mammography with mammography and sonogra-
phy in clinical routine practice. Findings for the three
diagnostic methods documented on routine reports that
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FFE = fast-field-echo; MR = magnetic resonance.
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Abstract
Patients with abnormal breast findings (n=413) were examined by mammography, sonography and
magnetic resonance (MR) mammography; 185 invasive cancers, 38 carcinoma in situ and 254 benign
tumours were confirmed histologically. Sensitivity for mammography was 83.7%, for sonography it was
89.1% and for MR mammography it was 94.6% for invasive cancers. In 42 patients with multifocal
invasive cancers, multifocality had been detected by mammography and sonography in 26.2%, and by
MR mammography in 66.7%. In nine patients with multicentric cancers, detection rates were 55.5,
55.5 and 88.8%, respectively. Carcinoma in situ was diagnosed by mammography in 78.9% and by
MR mammography in 68.4% of patients. Combination of all three diagnostic methods lead to the best
results for detection of invasive cancer and multifocal disease. However, sensitivity of mammography
and sonography combined was identical to that of MR mammography (ie 94.6%).
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were available to the surgeon preoperatively formed the
basis of this comparison. Special emphasis was placed
on the identification of multifocal and multicentric inva-
sive disease.
Patients and methods
Patients
Between September 1995 and September 1998, 413
patients with abnormal breast findings were referred for
histological evaluation to the Department of Gynecology
of the Friedrich-Schiller University, Jena, Germany.
Patients had been selected and referred because of the
presence of breast lesions detected by palpation and/or
mammography and/or sonography. In addition, MR mam-
mography was performed in all patients. We excluded five
patients with invasive cancer who had a history of core-
needle or fine-needle biopsy cancer within 2 weeks before
referral, because the presence of haematoma may mimic
false-positive findings on MR mammography. In addition,
five patients who did not keep still during MR mammogra-
phy were excluded.
Imaging
Analysis of the sonograms taken in patients with histologi-
cally confirmed carcinoma in situ were excluded from
analysis because the value of sonography for detection of
premalignant disease is limited. Mammography was not
performed in 32 patients who were younger than 30 years
or who had had a mastectomy with suspected local recur-
rence. For all patients, written reports of mammographic,
sonographic and dynamic MR mammographic findings
were available preoperatively.
The majority of mammograms (68%) were performed at
the Institute for Diagnostic and Interventional Radiology,
Friedrich-Schiller-University, using a senograph DMR (GE
Medical Systems, Milwaukee, Wisconsin, USA) with stan-
dard craniocaudal and mediolateral oblique projections.
Mammograms obtained at other institutions that were con-
sidered to match the quality standards of our institution
were also accepted for evaluation.
All sonography and MR examinations were carried out at
the Department of Gynecology and the Institute for Diag-
nostic Interventional Radiology, Friedrich-Schiller-University,
respectively. Sonography was done using a 7.5-MHz linear
array probe with a Sonoline Versa Pro (Siemens, Erlangen,
Germany). MR mammography was performed exclusively at
the Institute for Diagnostic Interventional Radiology, using a
Gyroscan ACS II (Philips, Nijmegen, The Netherlands) with
a field strength of 1.5 T using a double-breast coil. Dynamic
T1-weighted images were aquired using a multislice two-
dimensional fast-field-echo (FFE) sequence. We used the
following parameters: TR 97, TE 5.0, flip angle 80°, slice
thickness 4.0mm, gap 0.4mm, field of view 350mm and
transverse orientation. In addition T2-weighted images
(4000/300/90°/4.0mm/0.4/350mm) were obtained. As
contrast medium, 0.1mmol gadolinium-DTPA/kg body
weight (Magnevist; Schering, Berlin, Germany) was used
and injected as a bolus. One unenhanced and seven
enhanced studies were acquired with an acquisition time of
1min. Criteria for malignancy were signal enhancement of
90% or more within the first 2min after bolus injection and
signal plateau or washout phenomena afterward. Additional
criteria were irregular borders of the lesion and low signal
intensity in the T2-weighted images.
Mammograms were read by three different radiologists,
sonography was done by three different gynaecologists
and MR mammography was interpreted by a total of six
different radiologists.
Definition for multifocal carcinoma was a distance of less
than 3cm and for multicentric carcinoma a distance over
3cm between various lesions.
Statistical analysis
Interpretation of the various diagnostic procedures was
compared with the histological examination with regard to
sensitivity, specificity, accuracy, and positive and negative
predictive value. Criteria for suspected malignancy in the
written reports were the terms ‘cancer’, ‘malignant lesion
or tumor’, or ‘suspicious for cancer’. Sensitivity, specificity,
negative and positive predicitive value, and accuracy were
evaluated as follows:
Sensitivity = patients with suspected breast cancer/
patients with histologically confirmed breast cancer
Specificity = patients with suspected benign disease/
patients with histologically confirmed benign disease
Positive predictive value = patients with histologically con-
firmed breast cancer/patients with suspected breast cancer
Negative predictive value = patients with histologically
confirmed benign disease/patients with suspected benign
disease
Accuracy = patients with true-positive and true-negative
detected disease/patients with histologically confirmed
breast cancer
A result was classified as false-negative when a diagnostic
method classified a histologically confirmed cancer as
benign. A result was classified as false-positive when a
diagnostic method classified a histologically confirmed
benign lesion as cancer. We compared the preformance
of all diagnostic methods individually and in combination
using the results from all patients. Statistical analysis was
performed for all variables with Fisher’s exact test and
Pearson’s  c2 test.Results
All patients underwent breast surgery and all abnormal
lesions identified by mammography, sonography or MR
mammography were surgically removed. A total of 477
breast lesions were examined histologically, revealing the
presence of 185 invasive cancers, 38 carcinomata in situ
and 254 benign lesions (fibroadenoma, papilloma, intra-
ductal or adenoid ductal hyperplasia, cystic mastopathia).
There were four patients with malignant lesions in both
breasts. In 42 patients multifocal tumours and in nine
patients multicentric tumors were found on histological
examination. Among the 185 invasive lesions, 178 were
primary cancers, five were recurrences, one was metasta-
tic and one was an angiosarcoma. The majority of invasive
breast cancers were staged as pT1c (44%). Six per cent
of tumors were detected in stage pT1a, 18% in stage
pT1b, 25% in stage pT2, 3% in stage pT3 and 4% in
stage pT4. The distribution of histopathological tumour
types is shown in Table 1. The mean age of patients was
58 years (range 19–85 years).
The sensitivity of MR mammography was significantly
higher than those of mammography and sonography
(P<0.005 and P<0.05; Table 2). The specificity of
sonography was significantly higher than those of mam-
mography and MR mammography (P<0.05 and
P<0.005; Table 2). The negative predictive values for
sonography and MR mammography were significantly
higher than that of mammography (P<0.05 and
P<0.005; Table 2). With regard to accuracy, no signifi-
cant difference between the three modalities was found
(Table 2). Combining of all three diagnostic methods
yielded the best results for detection of cancer (P<0.005;
Table 3). The sensitivity and negative predictive value for
the combination of mammography and MR mammography,
and the combination of sonography and MR mammogra-
phy were significantly higher than those for the combina-
tion of mammograpy and sonography (P<0.05; Table 3).
The highest result for accuracy was seen for a combina-
tion of all three methods (P<0.05; Table 3).
Mammography was false-negative in 30 out of 184 invasive
cancers, sonography was false-negative in 20 out of 185
cancers, and 10 out of 185 invasive cancers were missed
by MR mammography. The majority of false-negative find-
ings was found in stage 1 disease, ductal carcinoma and
grade 3 tumors (Table 4). Of 10 invasive cancers missed
by MR mammography, eight were found by mammography
and sonography. By all three techniques, one invasive
ductal carcinoma (pT1b) was misinterpreted as fibroade-
noma. In another patient, a microinvasive lobular carcinoma
of 5mm diameter was not detected with mammography
and MR mammography, whereas sonography detected a
solid, benign tumour. MR mammography identified 10 inva-
sive cancers (5.2%) that were missed by mammography
and sonography, whereas one invasive cancer was found
by mammography alone. By sonography alone, not a single
case of invasive disease was detected when MR mammog-
raphy or mammography were nonsuspected.
The highest detection rate for multifocal invasive disease
was seen with MR mammography, which identified 28 out
of 42 (66.7%) histologically confirmed multifocal invasive
cancers, whereas mammography and sonography both
identified 11 (26.2%) of these cancers (P<0.05). The
combination of all three diagnostic methods leads to the
best result for detection of multifocality (76.2%; P<0.05),
whereas the detection rate with the combination of mam-
mography and sonography was 35.7%, with the combina-
tion of sonography and MR mammography it was 69%
(P<0.05 versus mammography + sonography), and with
the combination of mammography and MR mammography
it was 73.8% (P<0.05 versus mammography + sonogra-
phy). Multifocal invasive disease was suspected in 12
patients by mammography, in 13 patients by sonography,
and in 16 patients by MR mammography, but only unifocal
disease was confirmed by histology. Out of nine patients
with histologically confirmed multicentric invasive cancer,
eight (88.8%) of these cancers were detected by MR
mammography and five (55.5%) by mammography or
sonography. One patient was diagnosed with multicentric
invasive–lobular carcinoma stage pT2G2, which had been
misinterpreted as benign tumour by sonography and mam-
mography, and as haematoma by MR mammography.
Out of 38 patients with carcinoma in situ, mammography
(suspicious microcalcifications, exclusively) identified 30
cases (78.9%) and MR mammography identified 26 cases
(68.4%). When combining mammography and MR mam-
mography, sensitivity for detection of carcinoma in situ
increased to 87% (not significant).
Discussion
When the validity of individual diagnostic methods for
detection of invasive breast cancer was analyzed, the
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Table 1
Histopathology of 185 invasive cancers
Histopathologic diagnosis Number of lesions
Ductal carcinoma 109
Lobular carcinoma 36
Mixed ductal/lobular carcinoma 16
Mucinous carcinoma 2
Medullary carcinoma 3
Tubular carcinoma 13
Others (metaplastic carcinoma, 6
angiosarcoma, metastases)sensitivity and specificity of mammography ranged from
79.9 to 89% and from 64 to 93.5%, respectively [6,7,13];
for sonography from 67.6 to 96% and from 93 to 97.7%,
respectively [13,14]; and for MR mammography from 91
to 98.9 and from 20 to 97.4%, respectively [6–10,
15–17].
The performance of mammography, sonography and MR
mammography was compared in three large series
(Table 5). The present results are similar with regard to
sensitivity and specificity for the detection of malignant
breast lesions, with MR mammography reaching the
highest sensitivity of all imaging procedures.
When combinations of all three technique were analyzed,
mammography and sonography (standard method) had a
sensitivity of 83% and a specificity of 92% for detection of
malignant disease [3]. A combination of mammography,
sonography and MR mammography (combined method)
showed a sensitivity of 95% and a specificity of 64% [3].
For nonpalpable lesions, sensitivity increased from 73%
by the standard method to 82% for the combined method.
Specificity for the standard method (89%) was higher
than that for the combined method (71%). For palpable
lesions a sensitivity of 85% for the standard and 98% for
the combined method was achieved, whereas specificity
for the standard method was 100% compared with 45%
for the combined methods [3]. The positive predictive
value was 94% for the standard and 80% for the com-
bined methods, and the negative predictive values were
78 and 89%, respectively [3]. In the present study, we
also found the highest sensitivity, specificity, and positive
and negative predictive values for the combination of all
three methods. Combination of mammography and sonog-
raphy was as sensitive as MR mammography alone
(94.6% versus 94.6%).
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Table 2
Comparison of mammography, sonography and MR mammography for preoperative prediction of histologically confirmed invasive
cancer (n=185) or benign disease (n=254)
Diagnostic method Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
Mammography 83.7 68.5 67.8 84.1 77.1
Sonography 89.1 79.1*† 65.7 90.9‡ 83.4†
MR mammography 94.6*‡ 68.5 68.6 94.6† 79.5
*P<0.005, versus MR mammography; †P<0.05, versus mammography; ‡P<0.05, versus sonography. NPV, negative predictive value;
PPV, positive predictive value.
Table 3
Comparison of various combinations of three diagnostic methods for preoperative prediction of histologically confirmed invasive
cancer (n=185) or benign disease (n=254)
Diagnostic methods Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
Mammography + MR mammography 98.9* 90.5 88.4 99.1* 94.1
Sonography + MR mammography 98.9* 93.3 91.5 99.2* 95.7
Mammography + sonography 94.6 92.1 89.7 95.9 93.2
All three methods combined 99.4† 95.3 93.9 99.6† 97.0†‡
*P<0.05, versus mammography and sonography; †P<0.005, versus mammography and sonography; ‡P<0.05, versus MR mammography and
mammography. NPV, negative predictive value; PPV, positive predictive value.
Table 4
Analysis of false-negative diagnosis of mammography (n=30),
sonography (n=20) and MR mammography (n=10) for 185
invasive cancers
Cancer MR
characteristics Mammography Sonography mammography
Tumour stage
1 a 143
1 b 852
1c 11 6 3
2 622
3 110
4 (inflammatory) 3 2 0
Histological type
Ductal 15 13 2
Lobular 11 3 4
Others 4 4 4
Grading
1 231
21 0 6 5
31 8 1 1 4The majority of false-positive results for invasive cancer by
MR mammography (80 out of 439) were caused by papil-
lomas, intraductal hyperplasia grade 2 or 3, or fibroadeno-
mas in the present series. These lesions have a good
blood supply and may mimic invasive cancer [16,18].
Ten out of 185 (5.4%) malignant lesions were classified
as false-negative by MR mammography. On histology, the
majority of false-negative invasive cancers were lobular
cancers (four out of 10). Bone et al [18] reported false-
negative results in 11 out of 155 readings, with the major-
ity being lobular cancers on histology. Lack of
tumour-induced neovascularity may explain such findings.
In particular, invasive lobular cancers infiltrate the normal
tissue with columns of single cells, and receive adequate
oxygenation without the requirement for increased vascu-
larization [19]. Buadu et al [11] found that lobular and
mucinous carcinomas had a low microvessel density.
Multifocality of breast cancers can be recognized ade-
quately by MR mammography [20,21]. Boetes et al [22]
reported that all 61 multifocal cancers were detected by
MR mammography, compared with 31% by mammogra-
phy and 38% by sonography. Esserman et al [20]
detected multifocality by MR mammography in 100% (10
out of 10) versus 44% (four out of nine) by mammogra-
phy. Relevant changes in therapy due to additional multi-
centric and contralateral tumour findings by MR
mammography occur in 18% of patients as compared
with conventional imaging [23]. We found a detection rate
of multifocality of 66.7% by MR mammography, as com-
pared with 26.2% by mammography and sonography.
However, in 16 patients multifocal invasive disease as
diagnosed by MR mammography was shown to be unifo-
cal by histology.
Kramer et al [24] reported that MR mammography yielded
the highest sensitivity for detection of multicentricity as
compared with mammography and sonography (89, 66
and 79%, respectively) in 38 patients. These findings are
comparable with the present results, in which eight out of
nine multicentric cancers were diagnosed correctly.
Carcinoma in situ is identified by mammography through
the presence of suspicious microcalcifications. Suspicious
microcalcifications are more frequent in intraductal than in
infiltrating cancers [25], which was also observed in the
present series. Mammography showed a detection rate for
carcinoma in situ of 78.9%, as compared with 65.8% by
MR mammography; the combination of mammography and
MR mammography lead to a detection rate of 86.4%.
Fischer  et al [26] reported that carcinoma in situ was iden-
tified by MR mammography in 25 out of 35 patients (72%);
three ductal carcinomata in situ were detected by MR
mammography exclusively. Sittek et al [27] reported that
14 out of 20 carcinomata in situ (70%) were correctly
diagnosed by MR mammography on the basis of focal
increase of signal intensity. Those authors concluded that
carcinoma in situ is not reliably detected by MR mammo-
graphy because of lack of a uniform pattern of enhance-
ment. Esserman et al [20] reported a detection rate of 43%
for ductal carcinoma in situ by MR mammography. Among
36 woman with carcinoma in situ, Gilles et al [28] demon-
strated two cases without early contrast enhancement.
The present study showed that, for detection of breast
cancer, MR mammography is not superior to a combina-
tion of sonography and mammography. For identification
of multifocal or multicentric disease, MR mammography
proved to be the most accurate technique.
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